Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

From beer to drugs to cars: Global business laments EU vote

Fri, 24th Jun 2016 06:50

By Ben Hirschler and Martinne Geller

LONDON, June 24 (Reuters) - Shocked chief executives fromMumbai to Denver woke up on Friday to face tough decisions overhow to respond to Britain's vote to leave the European Union.

In Britain itself, businesses as diverse as engineeringgroup Rolls-Royce, drugs giant AstraZeneca, housebuilders and makers of Scotch whisky were braced fordisruption in the short and long term as the pound plunged toits lowest level since 1985.

Big business -- with a very few exceptions -- has beenstrongly in favour of remaining in the world's biggest tradingbloc, primarily because of ease of access to 500 millionEuropean consumers.

"The weeks and months ahead are going to be a nervy time forbusiness leaders," Simon Walker, director general of Britishbusiness lobby the Institute of Directors, said on Friday.

Jaguar Land Rover, Britain's biggest carmaker, has estimatedits annual profit could shrink by 1 billion pounds ($1.4billion) by 2020 if Britain returns to World Trade Organizationrules for trade with Europe.

Shares in the company's owner, India's Tata Motors, slumped more than 10 percent.

Makers of Scotch whisky, who export about 90 percent of whatthey produce, have stressed the importance of the EU, whichswallows about a third of those exports, but also the clout EUmembership gives in negotiations with fast-growing markets suchas India, which has a 150 percent tariff on imported spirits.

Some investors warned of a coming British or even globalrecession as sterling collapsed to hit its lowest since 1985,while FTSE futures fell 8 percent.

The president of Japan's Nippon Steel & Sumitomo Metal, the world's second-largest steelmaker, said the votewas extremely disappointing. "We are greatly concerned for thenegative impact this will have, not only on Britain and the EUbut also on the global economy," said Kosei Shindo.

Martin Sorrell, the boss of the world's biggest advertisinggroup WPP, said: "This decision will create tremendousuncertainty, which will slow economic activity and decisionmaking."

STERLING HEADACHE

Big swings in sterling will be a headache for someinternational companies, with a fall in the currency hittingprofits earned in Britain.

International companies with sizeable sterling exposureinclude Denver-based Molson Coors, owner of Carlingbeer, which is heavily reliant on the UK.

Aside from market access, streamlining of regulations withinthe EU has made life simpler.

Pharmaceutical companies, for example, enjoy a one-stop shopin the form of the European Medicines Agency -- based in London- which approves new drugs for all EU countries, while the EU'sopen airspace deals have fostered a surge in air travel andcommon policies on agriculture and food safety have allowed forsmoother supply chains and richer eating.

Companies in those sectors have fretted that Britain outsidethe bloc would disrupt the regulatory landscape.

"This creates immediate challenges for future investment,research and jobs in our industry in the UK," said MikeThompson, CEO of the Association of the British PharmaceuticalIndustry.

AstraZeneca said it was concerned for the competitiveness ofthe British life sciences industry and would work to ensurepatient access to medicines, amid worries that leaving the EUcould delay drug approvals.

Access to workers is another important factor for companies.Automotive industry executives, who are heavily reliant onexports, ranked tapping a skilled workforce a close second toaccessing EU markets in a survey on reasons to remain in March.

Ahead of the vote, some British-based multinationals such asDiageo, Unilever and Rolls-Royce had expressedtheir support for "Remain" directly to employees, although moststopped short of this.

Government figures show 12.6 percent of Britain's economicoutput is linked to exports to the EU's 27 other members, forwhom only 3.1 percent of output is linked to exports to Britain.And 80 percent of British businesses trading overseas do so withthe EU.

The Confederation of British Industry has estimated therecould be between 550,000 and 950,000 fewer jobs by 2020 in theevent of Brexit.

For banks, a huge concern has been the threat that financialinstitutions based in London could lose their EU "passports", orthe automatic right to sell services across the bloc undersingle low-cost system. That has made bank shares particularlyvolatile in the run-up to the referendum.

Brexit uncertainty has also helped push British merger andacquisition activity this year at its lowest as a proportion ofglobal activity since records began in 1980. ($1 = 0.7428 pounds) (Additional reporting by Kate Holton, Ritsuko Ando and YukaObayashi; Editing by Keith Weir)

More News
Today 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.